Sather Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-516
Closed -$209K 122
2025
Q2
$209K Hold
516
0.01% 109
2025
Q1
$257K Hold
516
0.02% 82
2024
Q4
$268K Hold
516
0.02% 77
2024
Q3
$319K Hold
516
0.02% 69
2024
Q2
$285K Hold
516
0.02% 72
2024
Q1
$300K Sell
516
-2
-0.4% -$1.12K 0.02% 78
2023
Q4
$275K Sell
518
-49
-9% -$23.7K 0.02% 78
2023
Q3
$287K Buy
567
+47
+9% +$25K 0.02% 79
2023
Q2
$271K Hold
520
0.02% 83
2023
Q1
$300K Buy
520
+48
+10% +$27.1K 0.03% 77
2022
Q4
$260K Buy
472
+52
+12% +$27.6K 0.02% 91
2022
Q3
$213K Hold
420
0.02% 72
2022
Q2
$228K Hold
420
0.02% 77
2022
Q1
$248K Hold
420
0.02% 85
2021
Q4
$280K Hold
420
0.02% 68
2021
Q3
$240K Buy
+420
New +$231K 0.02% 77

Other funds holding TMO

Sather Financial Group's TMO Position: Q3 2025 in Review

Sather Financial Group sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 516 shares — an estimated $209K sold.

Sather Financial Group first reported a position in TMO in Q3 2021 and held it in 16 quarters. The position peaked at $319K in Q3 2024. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Sather Financial Group reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Sather Financial Group sold 516 Thermo Fisher Scientific shares in Q3 2025, an estimated $209K.
  • Sather Financial Group first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 16 quarters.
  • Sather Financial Group's Thermo Fisher Scientific position peaked at $319K in Q3 2024.
  • 2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Sather Financial Group's 13F filing for Q3 2025, filed 22 Oct 2025.